Costs associated with attending medical appointments also play a significant role. Some 85 per cent said that mileage and travel costs added to their financial burden, 83 per cent had issues with ...

The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...

Tremfya is the first and only fully-human, dual-acting IL-23p19 subunit inhibitor approved in both ulcerative colitis and ...

The Crohn's and Colitis Foundation is hosting the West Michigan Take Steps event in Comstock Park on June 21, to raise money for research, treatments and programs aiding people living with IBD.

Patients with ulcerative colitis have a higher risk for cancer than the general population, with variations in cancer incidence more pronounced with age than with treatment status.

Bloating or abdominal pain can affect almost anyone. Sometimes, these symptoms can last for weeks or even months. Finding the ...

Specific protein signatures could predict a future diagnosis of Crohn disease and ulcerative colitis, potentially enabling ...

Chloe Meadows recently opened up about the condition. Here’s some expert advice if you think you might also have bowel issues ...

Quell and AstraZeneca entered a collaboration, exclusive option and license agreement in June 2023 to develop, manufacture and commercialize autologous, engineered Treg cell therapies for two ...

A Mediterranean plant shows promise in preventing ulcerative colitis damage in rats, offering a possible safer alternative to ...

A new study published in the Journal of Proteome Research offers hope for a simpler and less invasive way to tell Crohn’s ...